# Post-Market Observation Study of Intra-renal Drug Delivery (PROVIDE)

> **NCT01064895** · — · TERMINATED · sponsor: **Angiodynamics, Inc.**

## Conditions studied

- Acute Kidney Injury
- Acute Renal Failure
- Renal Failure Chronic Contrast Induced
- Chronic Kidney Disease

## Interventions

- **DEVICE:** Benephit catheter for Targeted Renal Therapy

## Key facts

- **NCT ID:** NCT01064895
- **Lead sponsor:** Angiodynamics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2010-02
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** — (—)
- **Last updated:** 2016-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01064895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01064895, "Post-Market Observation Study of Intra-renal Drug Delivery (PROVIDE)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01064895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*